Story thread · 2 reports / 2 sources
Aurinia Settles Patent Litigation with Teva
financialpost.com · 3h · first report
EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it and its subsidiary, Aurinia Pharma U.S., Inc., (collectively, “Aurinia”) have entered into a settlement agreement with Teva Pharmaceuticals Inc. (“Teva”) to resolve patent infringement litigation relating to Teva’s filing of an Abbreviated New Drug Application seeking to market its generic 7.9 mg voclosporin […]
The coverage
- Aurinia settles Lupkynis patent litigation with Teva
seekingalpha.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.